Riskpilot← Back to searchSign inGet full accessETAC AS
ASActiveOrg 876597152Vanemveien 1, 1599 MossWholesale of pharmaceutical and medical goods · NACE 4646Est. 199648 employeeswww.etac.com
Revenue 2024
NOK 343,9M
+11% vs 2023
EBITDA margin
6.3%
+2% vs 2023
Equity ratio
56.1%
Financial strength
Net profit 2024
NOK 20M
+5% vs 2023
| Revenue | NOK 343,9M | +11% |
| EBITDA | NOK 21,7M | +2% |
| Net profit | NOK 20M | +5% |
| Total assets | NOK 171,7M | +5% |
| Equity | NOK 96,2M | +0% |
| Employees | 48 | — |
Legal name
ETAC AS
Org number
876597152
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10. juli 1996
Share capital
NOK 364 000
Employees
48 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Vanemveien 1, 1599 Moss
Phone
+4781569469
Email
info@etac.de
Website
www.etac.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 376 701 | 257 753 | 282 348 | 309 455 | 343 871 |
| Staff expenses | −52 241 | −32 725 | −33 378 | −40 533 | −44 331 |
| EBITDA | 35 561 | 17 891 | 20 489 | 21 267 | 21 687 |
| Depreciation & amort. | −1 142 | −494 | −551 | −54 | −255 |
| EBIT | 34 419 | 17 397 | 19 938 | 21 213 | 21 432 |
| Net financials | 3 321 | 80 | −68 | 3 283 | 4 292 |
| Profit before tax | 37 740 | 17 477 | 19 870 | 24 497 | 25 724 |
| Tax | 7 549 | 3 848 | 4 378 | 5 394 | 5 694 |
| Net profit | 30 191 | 13 630 | 15 492 | 19 103 | 20 030 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 182 375 | 137 691 | 154 885 | 162 878 | 171 651 |
| Equity | 128 468 | 92 097 | 92 097 | 96 200 | 96 230 |
| Long-term debt | 1 566 | 757 | 701 | 966 | 682 |
| Short-term debt | 50 638 | 42 837 | 62 087 | 64 243 | 74 738 |
| Total debt | 52 204 | 43 594 | 62 788 | 65 209 | 75 421 |
EBITDA margin
6.3%
This company
15.8%
Market median
-60% vs market
20202024
Equity ratio
56.1%
This company
38.2%
Market median
+47% vs market
20202024
Return on equity
20.8%
This company
18.4%
Market median
+13% vs market
20202024
Net profit margin
5.8%
This company
8.1%
Market median
-28% vs market
20202024
Asset turnover
2.00×
This company
1.12×
Market median
+79% vs market
20202024
Debt / equity
0.78×
This company
0.62×
Market median
+26% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2025 | |
| Former (2) | ||
| Chairman | 2022 – 2025 | |
| Board of Directors | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Etac Ab | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ETAC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hilde Margrethe Gravnås | Chief Executive Officer | 0 companies |
| Glenn Karmisholt Kjær | Board of Directors | 0 companies |
| Michael Wirzberger | Chairman | 0 companies |
| Lars Magnus Björkqvist | Board of Directors | 0 companies |
| Pär Sigvard Åström | Chairman | 0 companies |